BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24643701)

  • 1. Incidence of venous thromboembolism (VTE) in ambulatory pancreatic cancer patients receiving chemotherapy and analysis of Khorana's predictive model.
    Muñoz Martín AJ; García Alfonso P; Rupérez Blanco AB; Pérez Ramírez S; Blanco Codesido M; Martín Jiménez M
    Clin Transl Oncol; 2014 Oct; 16(10):927-30. PubMed ID: 24643701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early venous thromboembolism at the beginning of palliative chemotherapy is a poor prognostic factor in patients with metastatic pancreatic cancer: a retrospective study.
    Kim JS; Kang EJ; Kim DS; Choi YJ; Lee SY; Kim HJ; Seo HY; Kim JS
    BMC Cancer; 2018 Dec; 18(1):1260. PubMed ID: 30558603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Di Nisio M; Ferrante N; De Tursi M; Iacobelli S; Cuccurullo F; Büller HR; Feragalli B; Porreca E
    Thromb Haemost; 2010 Nov; 104(5):1049-54. PubMed ID: 20806119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Predictive Khorana's model in patients with venous thromboembolic disease and cancer].
    Ugarte Fornell G; Otero Candelera R; Ferrer Galván M; Morillo Guerrero R; Elias Hernández T; Jara Palomares L
    Med Clin (Barc); 2013 Dec; 141(11):479-81. PubMed ID: 23790582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of venous thromboembolism on the natural history of pancreatic adenocarcinoma.
    Ouaissi M; Frasconi C; Mege D; Panicot-Dubois L; Boiron L; Dahan L; Debourdeau P; Dubois C; Farge D; Sielezneff I
    Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):436-42. PubMed ID: 26256090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel high-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients.
    Ferroni P; Martini F; Portarena I; Massimiani G; Riondino S; La Farina F; Mariotti S; Guadagni F; Roselli M
    Clin Lung Cancer; 2012 Nov; 13(6):482-7. PubMed ID: 22591606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents.
    Tully CM; Apolo AB; Zabor EC; Regazzi AM; Ostrovnaya I; Furberg HF; Rosenberg JE; Bajorin DF
    Cancer; 2016 Mar; 122(5):712-21. PubMed ID: 26618338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolic events in patients undergoing craniotomy for tumor resection: incidence, predictors, and review of literature.
    Rinaldo L; Brown DA; Bhargav AG; Rusheen AE; Naylor RM; Gilder HE; Monie DD; Youssef SJ; Parney IF
    J Neurosurg; 2019 Jan; 132(1):10-21. PubMed ID: 30611138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy).
    Riess H; Pelzer U; Hilbig A; Stieler J; Opitz B; Scholten T; Kauschat-Brüning D; Bramlage P; Dörken B; Oettle H
    BMC Cancer; 2008 Dec; 8():361. PubMed ID: 19055847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of venous thromboembolism after the initiation of chemotherapy predicts a poor prognosis in patients with unresectable metastatic pancreatic cancer who underwent first-line chemotherapy with gemcitabine plus nab-paclitaxel.
    Yamai T; Ikezawa K; Hiraga E; Kawamoto Y; Hirao T; Higashi S; Daiku K; Maeda S; Abe Y; Urabe M; Kai Y; Takada R; Nakabori T; Fukutake N; Uehara H; Fujita M; Ohkawa K
    PLoS One; 2022; 17(3):e0264653. PubMed ID: 35231078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensified chemotherapy and simultaneous treatment with heparin in outpatients with pancreatic cancer - the CONKO 004 pilot trial.
    Pelzer U; Hilbig A; Stieler JM; Bahra M; Sinn M; Gebauer B; Dörken B; Riess H
    BMC Cancer; 2014 Mar; 14():204. PubMed ID: 24641937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism in patients receiving perioperative chemotherapy for esophagogastric cancer.
    Khanna A; Reece-Smith AM; Cunnell M; Madhusudan S; Thomas A; Bowrey DJ; Parsons SL
    Dis Esophagus; 2014 Apr; 27(3):242-7. PubMed ID: 23651074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical presentation of venous thromboembolism in inflammatory bowel disease.
    Papay P; Miehsler W; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Sobala A; Weltermann A; Eichinger S; Novacek G
    J Crohns Colitis; 2013 Oct; 7(9):723-9. PubMed ID: 23127785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of Cancer after a Second Unprovoked Venous Thromboembolic Event.
    Rézig S; Mao RL; Couturaud F; Lacut K; Delluc A
    Thromb Haemost; 2019 Mar; 119(3):490-495. PubMed ID: 30685873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of venous thromboembolism (VTE)--after hip arthroscopy.
    Alaia MJ; Patel D; Levy A; Youm T; Bharam S; Meislin R; Bosco Iii J; Davidovitch RI
    Bull Hosp Jt Dis (2013); 2014; 72(2):154-8. PubMed ID: 25150343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study.
    Cohen AT; Katholing A; Rietbrock S; Bamber L; Martinez C
    Thromb Haemost; 2017 Jan; 117(1):57-65. PubMed ID: 27709226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Incidence of Arterial and Venous Thrombosis in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
    Kang A; Antonelou M; Wong NL; Tanna A; Arulkumaran N; Tam FWK; Pusey CD
    J Rheumatol; 2019 Mar; 46(3):285-293. PubMed ID: 30385704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients.
    Gritsiouk Y; Hegsted DA; Schlesinger P; Gardiner SK; Gubler KD
    Am J Surg; 2014 May; 207(5):648-51; discussion 651-2. PubMed ID: 24560359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and Risk of Venous Thromboembolism in Patients With Resectable Pancreatic Cancer Receiving Neoadjuvant Chemotherapy.
    Kamiya M; Kawahara S; Kamioka Y; Murakawa M; Aoyama T; Kobayashi S; Ueno M; Yamamoto N; Oshima T; Yukawa N; Rino Y; Masuda M; Morinaga S
    Anticancer Res; 2023 Apr; 43(4):1741-1747. PubMed ID: 36974795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of superficial venous thrombosis in primary care and risk of subsequent venous thromboembolic sequelae: a retrospective cohort study performed with routine healthcare data from the Netherlands.
    Geersing GJ; Cazemier S; Rutten F; Fitzmaurice DA; Hoes AW
    BMJ Open; 2018 Apr; 8(4):e019967. PubMed ID: 29678975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.